The present invention, in some embodiments thereof, relates to a method and system for attaching a device to a pliable surface and, more particularly, but not exclusively, to a method and system to attach a medical device to skin using a partially attached, variable stiffness adhesive system.
U.S. Pat. No. 6,585,707 to Cabiri discloses a system adapted to be disposed between a rigid or semi-rigid device and human skin for reliably attaching the device to the skin for an extended period of time. The system of Cabiri '707 includes a skin-contacting surface for adhering to human skin, and an opposed surface for attachment to a rigid or semi-rigid device. The system is attached along its opposed surface to a portion of the total area of the adjacent surface of the device. When the device is subjected to external stress, the stress is transmitted through the area of attachment and distributed to the unattached area. This minimizes stress on the skin and reduces the chance of detachment from the skin.
United States Patent Application No. 2007/0219597 discloses an adhesive patch system that may be used for affixing a pump or other object to a human body. Such an adhesive patch system may include two sets of adhesive members, each member including an adhesive material on at least one side so as to attach to the body. The members of the first set are spaced to allow the members of the second set to attach to the body in spaces provided between the members of the first set, and the members of the second set are spaced to allow members of the first set to detach from the body without detaching the members of the second set.
U.S. Pat. No. 8,025,658 discloses an adhesive patch of a medical device that may have selective areas with adhesive material of varying adhesion strengths. In other embodiments, an adhesive patch of a medical device may include adhesive material that may be activated by a catalyst to increase or decrease the adhesion strength of the adhesive material. In further embodiments, a medical device may include a pierceable membrane containing an agent, the pierceable membrane positioned to be pierced by a needle and to cause some of the agent to be carried to the user-patient.
U.S. Pat. No. 7,837,651 discloses a drug delivery infusion pump assembly which may include a cannula assembly comprising a cannula, which is disposable on the face of a patient, and which includes left and right cannula support wings each having a wing tip portion with an adhesive pad removably adhesively attachable to a side of the face of the patient. The adhesive pad may provide a more convenient cannula attachment for the patient than a conventional headband.
Additional background art includes adhesives for EKG electrodes and other electronic sensors having rigid and semi rigid bodies with sensing areas and or operational areas that touch or are inserted into the skin
According to an aspect of some embodiments of the present invention there is provided a system for anchoring a location on a surface of a medical infusion device to the skin of a user. The system may include an adhesive substrate for adhering to the skin of the user and an interface attaching the substrate to the surface of the device. The substrate may include a skirt extending beyond the interface. The skirt may be flexibly attached to the interface. The system may further include a stiffener stiffening a portion of the skirt. The stiffener may be less flexible than the substrate.
According to some embodiments of the invention, the stiffener may inhibit folding of the skirt under an out of plane bending force.
According to some embodiments of the invention, the out of plane bending force may include gravity.
According to some embodiments of the invention, the stiffener may be stiff enough to suspend the skirt against a gravity force.
According to some embodiments of the invention, the stiffener may be biased away from a skin attaching surface of the substrate.
According to some embodiments of the invention, the stiffener may extend the skirt away from the infusion device.
According to some embodiments of the invention, the stiffener may hold the substrate taut.
According to some embodiments of the invention, the system may further include an adhesive cover, and a tab for peeling the adhesive cover from the substrate. The stiffener may support the substrate adjacent to the tab, supplying an opposing force when peeling the cover away from the substrate.
According to some embodiments of the invention, the tab may be located on the skirt.
According to some embodiments of the invention, the stiffener may be stiff enough to resist a force on the substrate caused by peeling of the cover.
According to some embodiments of the invention, the system may further include a start location for removal of the adhesive system from the user. The stiffener may extend along a peeling line to the start location, facilitating removing of the adhesive from the user's skin.
According to some embodiments of the invention, the start location may be on the skirt.
According to some embodiments of the invention, the stiffener includes a sharp turn between the peeling line and the interface.
According to an aspect of some embodiments of the present invention there is provided a system for anchoring a medical infusion device to a skin of a recipient. The system may include an adhesive substrate configured for adhering to the skin of the user. The system may further include a location on a surface of the device to be held firmly to the skin of the user, and a multi-part adhesive cover. The system may further include a first tab for peeling a first part of the cover and a second tab for peeling a second part of the cover. The first tab may be located beside the second tab and the first tab may be separated from the second tab by a notch.
According to some embodiments of the invention, the notch may be wedge shaped.
According to some embodiments of the invention, the notch may be triangular.
According to some embodiments of the invention, the stiffener may interpose between at least a part of the surface and a remaining portion of the substrate.
According to some embodiments of the invention, the stiffener may extend beyond a boundary of the surface.
According to some embodiments of the invention, the substrate may extend beyond a boundary of the stiffener.
According to some embodiments of the invention, the substrate may be divided into a plurality of discrete portions. Each of the portions may be joined to a separate respective subsurface of the surface.
According to some embodiments of the invention, a portion of the stiffener may interpose between the interface and the substrate.
According to some embodiments of the invention, the location to be held stationary may include a needle insertion point and/or a sensor.
According to some embodiments of the invention, the interface may surround the stationary location on at least two sides.
According to some embodiments of the invention, the interface may surround the stationary location on at least three sides.
According to some embodiments of the invention, the interface may surround the stationary location completely.
According to some embodiments of the invention, the substrate may interpose between the stiffener and the interface.
According to some embodiments of the invention, the stiffener may include one or more ribs extending from the interface toward an edge of the substrate.
According to some embodiments of the invention, an unbacked section of the substrate may be surrounded on at least two sides by the stiffener.
According to some embodiments of the invention, the stiffener may be attached to the surface of the device and the substrate may be affixed to the stiffener.
According to some embodiments of the invention, an unbacked skirt of the substrate may surround the surface on at least two sides.
According to some embodiments of the invention, an unbacked skirt of the substrate may surround the surface on at least three sides.
According to some embodiments of the invention, an unbacked skirt of the substrate may surround the surface on all sides.
According to some embodiments of the invention, wherein the substrate is may not be directly attached to the surface.
According to some embodiments of the invention, the surface may be protected from inadvertent adhesion to the substrate.
According to an aspect of some embodiments of the present invention there is provided a system to remove a plurality of adhesive covers from an infusion device. The system may include a plurality of pull tabs, and at least one notch separating between two of the plurality of tabs.
According to an aspect of some embodiments of the present invention there is provided a method of installing an adhesive to a medical infusion device. The method may include attaching part of a stiffener layer to a surface of the device and affixing an adhesive substrate to the layer.
According to some embodiments of the invention, the method may further include leaving another portion of the substrate unbacked by the stiffener.
According to some embodiments of the invention, the attaching may be on at least three sides of a location to be held firmly with respect to a site on the skin of the user.
According to some embodiments of the invention, the interface may include at least one relatively flexible region at least one less flexible region.
According to an aspect of some embodiments of the present invention there is provided a system for anchoring a location on a surface of a medical infusion device to the skin of a user. The system may include a flexible adhesive substrate for adhering to the skin of the user and an interface attaching the substrate to the surface of the device. The interface may include at least one relatively flexible region and at least one less flexible region.
According to some embodiments of the invention, interface may be attached to a portion of the substrate.
According to some embodiments of the invention, the system may further include a stiffener affixed to an unattached portion of said substrate.
According to some embodiments of the invention, the system may further include an adhesive cover, and a tab for peeling the adhesive cover from the substrate. The stiffener may support the substrate adjacent to the tab, supplying an opposing force when peeling the cover away from the substrate.
According to some embodiments of the invention, the system may further include a start location for removal of the adhesive system from the user. The stiffener may extend along a peeling line to the start location, facilitating removing of the adhesive from the user's skin.
Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.
Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.
In the drawings:
The present invention, in some embodiments thereof, relates to a method and system for adhering a device to a pliable surface and, more particularly, but not exclusively, to a method and system to adhere a medical device to skin using a variable stiffness adhesive system.
An aspect of some embodiments is that the adhesive system may optionally be configured to anchor a part of the device to a fixed site on the user's skin. In some embodiments, a location on the device surface that is intended to be anchored to the user's skin may be totally surrounded and/or surrounded on at least two and/or three side by an interface attaching the surface to the adhesive system.
An aspect of some embodiments is that the adhesive system may optionally include a skirt region extending beyond the attaching interface. Optionally, the skirt region may be configured to have variable flexibility and/or elasticity and/or absorbency and/or breathability and/or adhesion.
Some surfaces adhered rigidly against a human skin may tend to detach for a few reasons including. For example, the weight of the device applied at a center of gravity at some distance from the skin surface may tend to peel the top edge of the device away from the skin. For example, the adhesive and/or the substrate may irritate the skin by retaining moisture and/or by applying stress forces and/or by preventing access to air. Irritation may cause the skin to slough off surface cells and the adhesive adhered to them. For example, as the skin stretches and/or flexes one part of the adhesive may be leveraged against another part, tearing the device away the adhered skin. Optionally, the flexible skirt region may reduce detachment associated with rigid and/or sealed surfaces, for example for one or more of reasons numerated above.
An aspect of some embodiments is that in the skirt region, the adhesive may optionally be applied to a substrate. Optionally the substrate may be breathable and/or absorbent and/or flexible and/or elastic. Alternatively or additionally the substrate may include a foam, for example flexible foams manufactured by Kendall Polychem or and Avery Dennison. Some examples of foams include Actiflex (made by Kendall Polychem and PVC1, a PVC closed cell foam made by Avery Dennison under the model number Q527297, or be made of woven and non-woven fabrics for example 3M#1776 0.3 mm White Spunlace Polyester Nonwoven with layer Acrylate and/or, Sontara marketed by Du Pont.
An aspect of some embodiments is that some locations the skirt may optionally include a stiffener. The stiffener may include, for example, a flexible plastic layer lending support to the substrate. Optionally the stiffener may be stiffer than the adhesive substrate but flexible enough to conform to the skin of the user. Alternatively or additionally, the stiffener may include a resin applied to stiffen certain parts of the adhesive substrate. In some embodiments, the stiffener may include a rib and/or a bend.
An aspect of some embodiments is that the stiffener may optionally be made of plastic, for example Polyethylene terephthalate (PET) having a thickness that may range for example between 0.1 and 0.8 mm. Other materials may also be used include for example Polycarbonate and/or ABS.
An aspect of some embodiments is that a skirt may optionally project beyond the edge of the device. For example the skirt may project for a minimum distance ranging between 2 to 30 mm. The maximum length of the skirt beyond the edge of the device may range for example between 15 and 30 mm. Optionally, the skirt may have a maximum length at the removal point from which the adhesive is configured to be peeled from the user's skin.
Optionally, the stiffener may support the substrate from out of plane bending forces and/or extend the substrate outward. Optionally, the stiffener may be designed to prevent the adhesive substrate from folding up or sticking to itself before adhesion to the user. Alternatively or additionally, the stiffener may help stabilize the device on the user's skin.
An aspect of some embodiments is that the device may be for example an infuser. Optionally, a part of the infuser held substantially stationary with respect to a fixed point on the user's skin may include, for example a needle insertion point. Optionally, the location may be held substantially stationary in the direction perpendicular to the skin surface (the needle may remain inserted at a substantially fixed depth that may range for example between 0.3 and 7.5 mm). Alternatively and/or additionally a device may be anchored to hold a needle substantially stationary in a lateral plane. In some embodiments, the needle may be held at an insertion angle that ranges for example between 20 and 90 from plane of the skin surface. Permissible fluctuations of the insertion angle may range between ±7 degrees. In some embodiments, fluctuations in the insertion depth (along the axis of the needle) during infusion may range, for example, between 0.1 and 0.5 mm.
An aspect of some embodiments is that an adhesive system may optionally be configured to anchor a sensor to a testing site on the user's skin. For example, the device may include a skin proximity sensor. Optionally, the adhesive may anchor the device holding the proximity sensor in constant contact with the user's skin. Additionally or alternatively, the adhesive may anchor the device holding a sensor stationary with respect the user's skin (for example the sensor may be held in the range of 0-25 degrees from the plane parallel to the surface of the skin and/or the sensor may be held at a fixed distance and/or depth±1.5 mm from the surface of the user's skin).
An aspect of some embodiments is that they may optionally include a preferred removal point. Optionally, at the removal point, the adhesive system may be configured to make it easy to grasp the adhesive and peel off the user's skin. For example, the stiffener may broaden near the removal point. Optionally, the stiffener may be shaped to lead outward from the interface and then turn sharply toward the removal point. Alternatively and or additional the adhesive may be lacking and/or reduced at the removable point. Optionally, the removal point may be marked for easy recognition.
An aspect of some embodiments is that a portion of the adhesive may optionally be protected from sticking to the adjacent surface of the device. Optionally the edge of the adhesive may be protected from sticking to adjacent surface, for example, by extending the edge of the adhesive beyond the adjacent surface of the device and/or by the stiffener intervening between the edge of the adhesive and the adjacent surface of the device.
An aspect of some embodiments is that a multipart protective cover may optionally be supplied for the adhesive surface. The protective cover may include one or more tabs for peeling off respective discrete parts of the cover. Optionally the tabs may be separated by one or more notches. In some embodiments, the width of the notch may range for example between 0.1 and 1 mm. In some embodiments, the length of the notch may range for example between 15-30 mm. Optionally, the shape of the notch may depend upon the form of the tabs. For example the notch may have a wedge and/or a triangular shape. In some embodiments, the stiffener may be configured to facilitate peeling of the cover from the adhesive. For example, the stiffener may supply extra support to the substrate at the tab location. For example the stiffener may prevent the substrate from bending more than 5 degrees when the cover is peeled from the substrate.
An aspect of some embodiments is that the interface connecting the adhesive substrate to the infuser may have a variable stiffness.
Exemplary embodiments of the invention are described in terms of an infusion device. It is understood that various other devices may also use an adhesion system as described herein. Unless stated otherwise, embodiments of the current invention should include various infusion devices, and/or other devices, for example iontophoretic drug delivery systems; minimally invasive sensors, including glucose sensors; diagnostic devices such as devices used in heart rate, pulse and ECG monitoring; ostomy products; nerve stimulators; external programming, data collection and monitoring devices for pace makers and defibrillators; implantable hearing aids and the like.
In some embodiments the adhesive system may be detachable from the infusion device. In some embodiments, a needle assembly may be attached to the injector via a flexible tube. Optionally, the needle assembly may be adhered independently of the body of the user.
Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.
Method of Adhering a Device to Skin
Adhering a device may start 102, for example by activating 104 the adhesive. Activating 104 the adhesive may include for example, removing a protective cover from an adhesive. Alternatively or additionally, activation 104 may include attaching an adhesive system to the infuser and/or putting a catalyst on an adhesive substrate.
In some embodiments of the present invention, the protective cover may be made of multiple sheets each sheet covering part of the adhesive. Optionally each sheet may have a separate pull tab. The tabs of the sheets may be located one next to the other with a notch separating between tabs of different sheets. In some embodiments, the notch may make their removal of the sheets more intuitive.
In some embodiments a stiffener may help prevent the adhesive substrate from folding up. Optionally, a portion of the stiffener may be located near the location from which the protective layer is to be peeled. Optionally, the stiffener may be thicker or wider at the location from which the adhesive cover is to be peeled. For example, the stiffener may include a rib which extends to the location of a pull tab from which the protective cover is to be peeled. In some embodiments, the form of the stiffener may make it easier to peel off the protective cover. For example, the stiffener may steady the adhesive as the user pulls away the cover. Alternatively or additionally, the adhesive and the stiffener may be configured to avert the adhesive contacting and/or sticking to the surface of the infuser.
The shape of the cover may be configured such that the pull tab provides good leverage for pulling off the whole cover. Optionally, the pull tab may be located close areas of exceptionally peeling difficulty. Optionally, there may be multiple tabs to provide improved leverage to multiple areas of the cover.
In some embodiments, after removing the protective cover, the device may be adhered 106 to the skin of the user.
In some embodiments, once the infuser is adhered 106 to the user, the infuser will sense its proximity 107 to the user. For example, the infuser may include an optional proximity sensor. The proximity sensor may include, for example, a mechanical switch, an optical sensor, a heat sensor, and/or an electrical resistance sensor. Optionally, the adhesive may be configured to hold tightly to the skin of the user at the location of the proximity sensor. Optionally, the infuser and/or the adhesive may be configured to avoid the user's skin folding at the location of the proximity sensor and/or the needle insertion point.
In some embodiments, a needle may be inserted 108 into the user. Alternatively or additionally there may be a catheter and/or a needless delivery system. Optionally, at the insertion point, the infuser may be held stationary with respect to the user's skin by the adhesive. Holding the insertion point stationary may, for example, avoid the needle moving in the skin, being removed, or causing unnecessary pain.
In some embodiments, once infusion has begun, the adhesive may hold 110 the infuser stably to the user until infusion finishes. The adhesive may have optional properties that increase the stability of the adhesion. For example, the adhesive substrate may be flexible and/or stretchable, for example to reduce strain on the adhesive when the user moves. For example, the adhesive substrate may be breathable and/or absorbent, for example to reduce skin irritation and resultant sloughing. In some embodiments, the stiffener may enhance the mechanical connection between some locations on the adhesive and the infuser.
Optionally, adherence to the skin may be enhanced by the presence of a flexible adhesive skirt around the area where the adhesive is rigidly and/or semi-rigidly attached to the infuser. The weight of the infuser may be applied to the skirt region as a sheering stress rather than a peeling stress. The skirt may optionally reduce the probability that the infuser will spontaneously peel off the user.
In some embodiments, the adhesive may be supported by a flexible substrate. Optionally the substrate may have properties that improve adherence to the skin and/or reduce skin irritation. Optionally, the substrate may comply with the skin. For example the substrate may be flexible and/or elastic and/or breathable and/or absorbent. Optionally, in some locations, the substrate will be free to stretch or flex. Optionally, at some locations, the substrate will be supported by a stiffener. The stiffener may, for example make it easier to apply the adhesive to the skin and/or the stiffener may enhance the mechanical connection between the infuser and a peripheral area of the adhesive.
In some embodiments, after infusion has finished, the infuser may be removed 112 from the user. Optionally, the adhesive system may be designed to facilitate removal 112. For example, there may be an intuitive mark of a preferred removal point. For example, there may be enhancements to make it the removal location easier to grasp and/or reduce the adhesion at removal location. The geometry of the adhesive may be configured so that the removal location has good leverage for removal of a large portion of the adhered surface.
After removal 112, infusions may optionally end 114 and the infuser may optionally be disposed of, for example by throwing it into the municipal garbage and/or into medical and/or hazardous waste.
Exemplary Infuser Having a Skin Sensor Near Edge
Some embodiments may include an optional sensor, for example a mechanical skin proximity sensor 224. Optionally, sensor 224 may include a needle insertion point 226. In exemplary embodiment 220, proximity sensor 224 is located near the edge of the injector.
Optionally, for example as illustrated in
Optionally, near proximity sensor 224 the skirt may be wider and/or include extra stiffener 216. In some embodiments, stiffener 216 may help hold proximity sensor 224 tightly against the skin of the user. In some embodiments, the stiffened skirt may help to avoid sensor 224 falsely registering removal of the device from the skin, for example when the user twists or moves.
In some embodiments, stiffener 216 may extend a skirt of substrate 218 away from the infuser. For example, stiffener 216 includes ribs 228a,b. Optionally, ribs 228a,b may serve for example to extend substrate 218 away from the infuser. Extending the skirt may, optionally, prevent substrate 218 from folding over onto itself, for example, before being attached to a user.
In some embodiments, sections of adhesive substrate 218 may not be backed by stiffener 216 and/or may not be attached to the surface of the injector. In some embodiments, the unbacked adhesive substrate 218 may be more flexible and/or elastic and/or breathable than the areas with backing. In the exemplary embodiment 220, for example, the edges of the skirt and some internal regions of the adhesive substrate are unbacked.
Optionally, rib 228a may widen near an edge which is to be used as a start location 234 for removal of the infuser from the user. For example, after infusion has finished a user may grasp location 234 and peel the infuser off his skin. The widening of rib 228a may, in some embodiments, may it easier to grasp the adhesive substrate to peel it off of the skin of the user. Alternatively or additionally stiffener 216 may extend beyond adhesive substrate 218 at removal location 234. Alternatively or additionally, the adhesive may be reduced, removed, and/or covered near removal location 234. In the exemplary embodiment of
In
Optionally, the geometry of the adhesive system may be configured to make peeling off the adhesive cover easier and/or more intuitive. For example, near the peeling location, the adhesive matrix may be stiffened by the stiffener and/or by an interface to the infuser
Optionally, ribs 228a,b and ribs 328a,b,c may extend toward the edges of adhesive substrate 218. Optionally there may be unbacked areas 335a,b,c,d of the adhesive substrate, for example on the edges (for example unbacked area 335c,d) and/or between ribs 228a,b and ribs 328a,b and ribs (for example, unbacked areas 335a,b). In some embodiments, an unbacked area (for example areas 335a,b) may be located between the skin of a user and the adjacent surface of the infuser and/or beyond an edge 325 of the infuser (for example areas 335c,d).
In the exemplary embodiment of
In some embodiments, interface 430 may not surround the proximity sensor and/or the needle insertion point (for example when the top of the proximity sensor reaches the edge 325 of the adjacent surface [as illustrated in
In some embodiments, part or the entire stiffener 216 may extend away from needle insertion point 226 and or proximity sensor 224. Optionally, part of the extension may be attached to the adjacent surface of the infuser, for example section of rib 328c is attached to the adjacent surface by an extension 438 of interface 430. Optionally, parts of stiffener 216 may be affixed to part of the adhesive substrate 218 but not attached to the adjacent surface of the infuser. Optionally, parts of stiffener 216 may intervene between substrate 218 and the adjacent surface of the infuser and/or may protrude out from edge 325 of the infuser.
In some embodiments, a portion of stiffener 216 may support substrate 218 adjacent to a peeling tab 242a. For example, rib 328b may supply an opposing force pulling adhesive 218 from tab 242b as cover 222b is peeled away substrate 218. In some embodiments, cover 222a,b and/or tabs 242a,b may be configured to avoid liner tear. For example, the shape may encourage pulling along a rolling line. For example a tab may be located at a sharp and/or rounded corner of the cover.
Exemplary Interface Surrounding Proximity Sensors and/or Needle Insertion Point
In some embodiments stiffener 516 may be biased. For example ribs 528a,c may be biased upward 527a away from the user's skin. Alternatively or additionally, 528a,c may be biased outward 527b, extending substrate 518 and/or holding it taut. Optionally, when the infuser is held above the skin of the user, ribs 528a,c may hold the skirt of substrate 518 upwards away from the skin attaching surface, preventing it from folding downward.
In some embodiments ribs 528a,b,c,d may extend from an attached area 530a,b toward the periphery of adhesive substrate 518.
Options, Alternatives and Additional Aspects
In the exemplary embodiment of
In some embodiments, an adhesive substrate may be attached in all or in part directly to an adjacent surface of an infuser. For example, substrate 618b is attached directly to the surface of the infuser in interface 630b in the vicinity of needle insertion point 626. Optionally an area 635e of interface 630b near insertion point 626 may be stiff. Optionally an area 635f of interface 630b further from insertion point 626 may be relatively flexible. For example in area 635f flexible padding may intervene between the surface of the infuser and substrate 618b (in the exemplary embodiment of
In some embodiments, an adhesive substrate may be affixed to a flexible stiffener extending away from an interface. For example an adhesive substrate 618c is shown affixed to a portion of flexible stiffener 616c extending away from an interface 630c. In the example of
In some embodiments, a stiffener layer may not be directly attached to the infuser. For example, stiffener 616d is not directly attached to the infuser. Stiffener 616d is affixed to adhesive substrate 618d which is attached to the infuser at interface 630d.
In some embodiments, the adhesive substrate may have a skirt partially surrounded the interface joining the adhesive to the device. For example, adhesive substrates 618c and 618d have skirts surrounding the respective interfaces 630c and 630d on only two sides. Alternatively or additionally, the skirt may surround the interface on all sides. For example, areas 335a,b,c,d surround interface 430 on all sides.
Optionally, the surface of the infuser that is adjacent to the user's skin may be shaped to facilitate placing flat against the skin. A stiffener may also optionally be designed for conforming to the skin surface during placement. Optionally, the infuser may be shaped to encourage proper placement of the device. Optionally the infuser may be designed to avoid placement of the needle insertion point and/or the skin proximity sensor near a fold in the skin of the user.
Exemplary Method of Mounting an Adhesive on an Infuser
The method may start, for example, by attaching 774 a portion of the stiffener to a surface of the infuser. Alternatively or additionally, the stiffener may be attached to a coupling that can be removably attached to the infuser.
In some embodiments, an adhesive substrate may be affixed 778 to the stiffener. Alternatively or additionally, the adhesive substrate may be affixed directly to the infuser.
In some embodiments an adhesive surface may be covered 780 with a protective cover.
General
In some embodiments, some layers may be supplied in a prebonded state. For example, the adhesive substrate may be supplied with the adhesive cover already in place. Optionally the adhesive substrate and/or the stiffener layer may also be supplied in a precut form.
It is expected that during the life of a patent maturing from this application many relevant adhesives, substrates and stiffener materials will be developed and the scope of the terms are intended to include all such new technologies a priori. As used herein the term “about” refers to ±5%
The terms “comprises”, “comprising”, “includes”, “including”, “having” and their conjugates mean “including but not limited to”.
The term “consisting of” means “including and limited to”.
The term “consisting essentially of” means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.
As used herein, the singular form “a”, “an” and “the” include plural references unless the context clearly dictates otherwise. For example, the term “a compound” or “at least one compound” may include a plurality of compounds, including mixtures thereof.
Throughout this application, various embodiments of this invention may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.
Whenever a numerical range is indicated herein, it is meant to include any cited numeral (fractional or integral) within the indicated range. The phrases “ranging/ranges between” a first indicate number and a second indicate number and “ranging/ranges from” a first indicate number “to” a second indicate number are used herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numerals therebetween.
It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.
Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.
All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.
Number | Name | Date | Kind |
---|---|---|---|
1795630 | Wilson | Mar 1931 | A |
2860635 | Wilburn | Nov 1958 | A |
3203269 | Perrine | Aug 1965 | A |
3212685 | Swan et al. | Oct 1965 | A |
3794028 | Mueller et al. | Feb 1974 | A |
3994295 | Wulff | Nov 1976 | A |
4195636 | Behnke | Apr 1980 | A |
4218724 | Kaufman | Aug 1980 | A |
4273122 | Whitney et al. | Jun 1981 | A |
4300554 | Hessberg et al. | Nov 1981 | A |
4403987 | Gottinger | Sep 1983 | A |
4435173 | Siposs et al. | Mar 1984 | A |
4465478 | Sabelman et al. | Aug 1984 | A |
4565543 | Bekkering et al. | Jan 1986 | A |
4585439 | Michel | Apr 1986 | A |
4599082 | Grimard | Jul 1986 | A |
4601702 | Hudson | Jul 1986 | A |
4685903 | Cable et al. | Aug 1987 | A |
4698055 | Sealfon | Oct 1987 | A |
4810215 | Kaneko | Mar 1989 | A |
4850966 | Grau et al. | Jul 1989 | A |
4867743 | Vaillancourt | Sep 1989 | A |
4886499 | Cirelli et al. | Dec 1989 | A |
4919596 | Slate et al. | Apr 1990 | A |
4929241 | Kulli | May 1990 | A |
4950246 | Muller | Aug 1990 | A |
D322671 | Szwarc | Dec 1991 | S |
5109850 | Blanco et al. | May 1992 | A |
5112317 | Michel | May 1992 | A |
5131816 | Brown et al. | Jul 1992 | A |
5190521 | Hubbard et al. | Mar 1993 | A |
5254096 | Rondelet et al. | Oct 1993 | A |
5300045 | Plassche, Jr. | Apr 1994 | A |
5342313 | Campbell et al. | Aug 1994 | A |
5348544 | Sweeney et al. | Sep 1994 | A |
5366498 | Brannan et al. | Nov 1994 | A |
5383865 | Michel | Jan 1995 | A |
5478315 | Brothers et al. | Dec 1995 | A |
5482446 | Williamson et al. | Jan 1996 | A |
5496274 | Graves et al. | Mar 1996 | A |
5501665 | Jhuboo et al. | Mar 1996 | A |
5505709 | Funderburk et al. | Apr 1996 | A |
5562686 | Sauer et al. | Oct 1996 | A |
5593390 | Castellano et al. | Jan 1997 | A |
5616132 | Newman | Apr 1997 | A |
5643218 | Lynn et al. | Jul 1997 | A |
5645955 | Maglica | Jul 1997 | A |
5647853 | Feldmann et al. | Jul 1997 | A |
5662678 | Macklin | Sep 1997 | A |
5672160 | Osterlind et al. | Sep 1997 | A |
5690618 | Smith et al. | Nov 1997 | A |
D393314 | Meisner et al. | Apr 1998 | S |
5766186 | Faraz et al. | Jun 1998 | A |
5795675 | Maglica | Aug 1998 | A |
5800420 | Gross et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5814020 | Gross | Sep 1998 | A |
5836920 | Robertson | Nov 1998 | A |
5848991 | Gross et al. | Dec 1998 | A |
5851197 | Marano et al. | Dec 1998 | A |
5858001 | Tsals et al. | Jan 1999 | A |
5858008 | Capaccio | Jan 1999 | A |
5868710 | Battiato et al. | Feb 1999 | A |
5931814 | Alex et al. | Aug 1999 | A |
5941850 | Shah et al. | Aug 1999 | A |
5948392 | Haslwanter et al. | Sep 1999 | A |
5954697 | Srisathapat et al. | Sep 1999 | A |
5957895 | Sage et al. | Sep 1999 | A |
5968011 | Larsen et al. | Oct 1999 | A |
5993423 | Choi | Nov 1999 | A |
6004297 | Steenfeldt-Jensen et al. | Dec 1999 | A |
6033245 | Yamkovoy | Mar 2000 | A |
6033377 | Rasmussen et al. | Mar 2000 | A |
6064797 | Crittendon et al. | May 2000 | A |
6074369 | Sage et al. | Jun 2000 | A |
6149614 | Dunshee | Nov 2000 | A |
6186982 | Gross et al. | Feb 2001 | B1 |
6200289 | Hochman et al. | Mar 2001 | B1 |
6200296 | Dibiasi et al. | Mar 2001 | B1 |
6224569 | Brimhall | May 2001 | B1 |
6248093 | Moberg | Jun 2001 | B1 |
6277095 | Kriesel et al. | Aug 2001 | B1 |
6277098 | Klitmose et al. | Aug 2001 | B1 |
6277099 | Strowe et al. | Aug 2001 | B1 |
6287283 | Ljunggreen et al. | Sep 2001 | B1 |
6293925 | Safabash et al. | Sep 2001 | B1 |
6302633 | Poe | Oct 2001 | B1 |
6336729 | Pavelle et al. | Jan 2002 | B1 |
6345968 | Shupe | Feb 2002 | B1 |
6377848 | Garde et al. | Apr 2002 | B1 |
6391005 | Lum et al. | May 2002 | B1 |
6423029 | Elsberry | Jul 2002 | B1 |
D465026 | May et al. | Oct 2002 | S |
6458102 | Mann et al. | Oct 2002 | B1 |
6485461 | Mason et al. | Nov 2002 | B1 |
6485465 | Moberg et al. | Nov 2002 | B2 |
6500150 | Gross et al. | Dec 2002 | B1 |
6503231 | Prausnitz et al. | Jan 2003 | B1 |
6511336 | Turek et al. | Jan 2003 | B1 |
6517517 | Farrugia et al. | Feb 2003 | B1 |
D471274 | Diaz et al. | Mar 2003 | S |
D471983 | Hippolyte et al. | Mar 2003 | S |
6558351 | Steil et al. | May 2003 | B1 |
6589229 | Connelly et al. | Jul 2003 | B1 |
6595956 | Gross et al. | Jul 2003 | B1 |
6595960 | West et al. | Jul 2003 | B2 |
6645181 | Lavi et al. | Nov 2003 | B1 |
6652482 | Hochman | Nov 2003 | B2 |
6656158 | Mahoney et al. | Dec 2003 | B2 |
6656159 | Flaherty | Dec 2003 | B2 |
6659980 | Moberg et al. | Dec 2003 | B2 |
6673033 | Sciulli et al. | Jan 2004 | B1 |
6679862 | Diaz et al. | Jan 2004 | B2 |
6689118 | Alchas et al. | Feb 2004 | B2 |
6699218 | Flaherty et al. | Mar 2004 | B2 |
6722916 | Buccinna et al. | Apr 2004 | B2 |
6743211 | Prausnitz et al. | Jun 2004 | B1 |
6749587 | Flaherty | Jun 2004 | B2 |
6752787 | Causey, III et al. | Jun 2004 | B1 |
6768425 | Flaherty et al. | Jul 2004 | B2 |
6786890 | Preuthun et al. | Sep 2004 | B2 |
6800071 | McConnell et al. | Oct 2004 | B1 |
6805687 | Dextradeur et al. | Oct 2004 | B2 |
6824529 | Gross et al. | Nov 2004 | B2 |
6843782 | Gross et al. | Jan 2005 | B2 |
6854620 | Ramey | Feb 2005 | B2 |
6905298 | Haring | Jun 2005 | B1 |
6908452 | Diaz et al. | Jun 2005 | B2 |
6960192 | Flaherty et al. | Nov 2005 | B1 |
6997727 | Legrady et al. | Feb 2006 | B1 |
7001360 | Veasey et al. | Feb 2006 | B2 |
7034223 | Fan et al. | Apr 2006 | B2 |
7048715 | Diaz et al. | May 2006 | B2 |
7060054 | Nissels | Jun 2006 | B2 |
7060059 | Keith et al. | Jun 2006 | B2 |
7097637 | Triplett et al. | Aug 2006 | B2 |
7128727 | Flaherty et al. | Oct 2006 | B2 |
7144384 | Gorman et al. | Dec 2006 | B2 |
D544092 | Lewis | Jun 2007 | S |
7225694 | Said | Jun 2007 | B2 |
7247149 | Beyerlein | Jul 2007 | B2 |
7250037 | Shermer et al. | Jul 2007 | B2 |
7267669 | Staunton et al. | Sep 2007 | B2 |
7291132 | DeRuntz et al. | Nov 2007 | B2 |
7291159 | Schmelzeisen-Redeker et al. | Nov 2007 | B2 |
7303549 | Flaherty et al. | Dec 2007 | B2 |
7344385 | Chen | Mar 2008 | B2 |
7364570 | Gerondale et al. | Apr 2008 | B2 |
7390314 | Stutz, Jr. et al. | Jun 2008 | B2 |
7407493 | Cane′ | Aug 2008 | B2 |
D578210 | Muta et al. | Oct 2008 | S |
7455663 | Bikovsky | Nov 2008 | B2 |
7465290 | Reilly | Dec 2008 | B2 |
7488181 | van Haaster | Feb 2009 | B2 |
7497842 | Diaz et al. | Mar 2009 | B2 |
7501587 | English | Mar 2009 | B2 |
7503786 | Kato et al. | Mar 2009 | B2 |
7530964 | Lavi et al. | May 2009 | B2 |
7547281 | Hayes et al. | Jun 2009 | B2 |
7565208 | Harris et al. | Jul 2009 | B2 |
7569050 | Moberg et al. | Aug 2009 | B2 |
D600341 | Loerwald | Sep 2009 | S |
7585287 | Bresina et al. | Sep 2009 | B2 |
7588559 | Aravena et al. | Sep 2009 | B2 |
7589974 | Grady et al. | Sep 2009 | B2 |
D602155 | Foley et al. | Oct 2009 | S |
D602586 | Foley et al. | Oct 2009 | S |
D604835 | Conley | Nov 2009 | S |
7628770 | Ethelfeld | Dec 2009 | B2 |
7628772 | McConnell et al. | Dec 2009 | B2 |
7628782 | Adair et al. | Dec 2009 | B2 |
7637891 | Wall | Dec 2009 | B2 |
7637899 | Woolston et al. | Dec 2009 | B2 |
7641649 | Moberg et al. | Jan 2010 | B2 |
7660627 | McNichols et al. | Feb 2010 | B2 |
7678079 | Shermer et al. | Mar 2010 | B2 |
7682338 | Griffin | Mar 2010 | B2 |
7686787 | Moberg et al. | Mar 2010 | B2 |
7699829 | Harris et al. | Apr 2010 | B2 |
7699833 | Moberg et al. | Apr 2010 | B2 |
7704088 | Sakamoto | Apr 2010 | B2 |
7704227 | Moberg et al. | Apr 2010 | B2 |
7704229 | Moberg et al. | Apr 2010 | B2 |
7704231 | Pongpairochana et al. | Apr 2010 | B2 |
7708717 | Estes et al. | May 2010 | B2 |
7713238 | Mernoe | May 2010 | B2 |
7713240 | Istoc et al. | May 2010 | B2 |
7717913 | Novak et al. | May 2010 | B2 |
7722574 | Toman et al. | May 2010 | B2 |
7736344 | Moberg et al. | Jun 2010 | B2 |
7744589 | Mounce et al. | Jun 2010 | B2 |
7749194 | Edwards et al. | Jul 2010 | B2 |
7776030 | Estes et al. | Aug 2010 | B2 |
7780637 | Jerde et al. | Aug 2010 | B2 |
7789857 | Moberg et al. | Sep 2010 | B2 |
7801599 | Young et al. | Sep 2010 | B2 |
7806868 | De Polo et al. | Oct 2010 | B2 |
7828528 | Estes et al. | Nov 2010 | B2 |
7837659 | Bush, Jr. et al. | Nov 2010 | B2 |
7846132 | Gravesen et al. | Dec 2010 | B2 |
7854723 | Hwang et al. | Dec 2010 | B2 |
7857131 | Vedrine | Dec 2010 | B2 |
7879025 | Jacobson et al. | Feb 2011 | B2 |
7918825 | O'Connor et al. | Apr 2011 | B2 |
7935104 | Yodfat et al. | May 2011 | B2 |
7935105 | Miller et al. | May 2011 | B2 |
7938803 | Mernoe et al. | May 2011 | B2 |
7955305 | Moberg et al. | Jun 2011 | B2 |
7967784 | Pongpairochana et al. | Jun 2011 | B2 |
7967795 | Cabiri | Jun 2011 | B1 |
7981105 | Adair et al. | Jul 2011 | B2 |
7988683 | Adair et al. | Aug 2011 | B2 |
7993300 | Nyholm et al. | Aug 2011 | B2 |
7993301 | Boyd et al. | Aug 2011 | B2 |
7998111 | Moberg et al. | Aug 2011 | B2 |
8021357 | Tanaka et al. | Sep 2011 | B2 |
8025658 | Chong et al. | Sep 2011 | B2 |
8029469 | Ethelfeld | Oct 2011 | B2 |
8034019 | Nair et al. | Oct 2011 | B2 |
8038666 | Triplett et al. | Oct 2011 | B2 |
8057431 | Woehr et al. | Nov 2011 | B2 |
8057436 | Causey et al. | Nov 2011 | B2 |
8062253 | Nielsen et al. | Nov 2011 | B2 |
8066694 | Wagener | Nov 2011 | B2 |
D650079 | Presta et al. | Dec 2011 | S |
D650903 | Kosinski et al. | Dec 2011 | S |
8086306 | Katzman et al. | Dec 2011 | B2 |
D652503 | Cameron et al. | Jan 2012 | S |
8105279 | Mernoe et al. | Jan 2012 | B2 |
8114046 | Covino et al. | Feb 2012 | B2 |
8114064 | Alferness et al. | Feb 2012 | B2 |
8114066 | Naef et al. | Feb 2012 | B2 |
D657462 | Siroky | Apr 2012 | S |
8147446 | Yodfat et al. | Apr 2012 | B2 |
8152764 | Istoc et al. | Apr 2012 | B2 |
8152770 | Reid | Apr 2012 | B2 |
8152779 | Cabiri | Apr 2012 | B2 |
8152793 | Keinanen et al. | Apr 2012 | B2 |
8157693 | Waksmundzki | Apr 2012 | B2 |
8162674 | Cho et al. | Apr 2012 | B2 |
8162923 | Adams et al. | Apr 2012 | B2 |
8167841 | Teisen-Simony et al. | May 2012 | B2 |
8172591 | Wertz | May 2012 | B2 |
8172804 | Bikovsky | May 2012 | B2 |
8182462 | Istoc et al. | May 2012 | B2 |
8197444 | Bazargan et al. | Jun 2012 | B1 |
8206351 | Sugimoto et al. | Jun 2012 | B2 |
8221356 | Enggaard et al. | Jul 2012 | B2 |
8267921 | Yodfat et al. | Sep 2012 | B2 |
8287520 | Drew et al. | Oct 2012 | B2 |
8292647 | McGrath et al. | Oct 2012 | B1 |
8308679 | Hanson et al. | Nov 2012 | B2 |
8323250 | Chong et al. | Dec 2012 | B2 |
8372039 | Mernoe et al. | Feb 2013 | B2 |
8373421 | Lindegger et al. | Feb 2013 | B2 |
8409142 | Causey et al. | Apr 2013 | B2 |
8414557 | Istoc et al. | Apr 2013 | B2 |
8430847 | Mernoe et al. | Apr 2013 | B2 |
8465455 | Cabiri | Jun 2013 | B2 |
8469942 | Kow et al. | Jun 2013 | B2 |
8474332 | Bente, IV et al. | Jul 2013 | B2 |
8475408 | Mernoe et al. | Jul 2013 | B2 |
8479595 | Vazquez et al. | Jul 2013 | B2 |
8495918 | Bazargan et al. | Jul 2013 | B2 |
8496862 | Zelkovich et al. | Jul 2013 | B2 |
8512287 | Cindrich et al. | Aug 2013 | B2 |
8517987 | Istoc et al. | Aug 2013 | B2 |
8523803 | Favreau | Sep 2013 | B1 |
8556856 | Bazargan et al. | Oct 2013 | B2 |
8562364 | Lin et al. | Oct 2013 | B2 |
8574216 | Istoc et al. | Nov 2013 | B2 |
8603026 | Favreau | Dec 2013 | B2 |
8603027 | Favreau | Dec 2013 | B2 |
8628510 | Bazargan et al. | Jan 2014 | B2 |
8674288 | Hanson et al. | Mar 2014 | B2 |
8679060 | Mernoe et al. | Mar 2014 | B2 |
8690855 | Alderete, Jr. et al. | Apr 2014 | B2 |
8708961 | Field et al. | Apr 2014 | B2 |
8751237 | Kubota | Jun 2014 | B2 |
8753326 | Chong et al. | Jun 2014 | B2 |
8753331 | Murphy | Jun 2014 | B2 |
8764707 | Moberg et al. | Jul 2014 | B2 |
8764723 | Chong et al. | Jul 2014 | B2 |
8771222 | Kanderian, Jr. et al. | Jul 2014 | B2 |
8777896 | Starkweather et al. | Jul 2014 | B2 |
8777924 | Kanderian, Jr. et al. | Jul 2014 | B2 |
8777925 | Patton | Jul 2014 | B2 |
8784369 | Starkweather et al. | Jul 2014 | B2 |
8784370 | Lebel et al. | Jul 2014 | B2 |
8790295 | Sigg et al. | Jul 2014 | B1 |
8795224 | Starkweather et al. | Aug 2014 | B2 |
8795231 | Chong et al. | Aug 2014 | B2 |
8795260 | Drew | Aug 2014 | B2 |
8801668 | Ali et al. | Aug 2014 | B2 |
8801679 | Iio et al. | Aug 2014 | B2 |
8810394 | Kalpin | Aug 2014 | B2 |
8814379 | Griffiths et al. | Aug 2014 | B2 |
8920374 | Bokelman et al. | Dec 2014 | B2 |
9061104 | Daniel | Jun 2015 | B2 |
9061110 | Avery et al. | Jun 2015 | B2 |
9089475 | Fangrow | Jul 2015 | B2 |
9089641 | Kavazov | Jul 2015 | B2 |
20010025168 | Gross et al. | Sep 2001 | A1 |
20010041869 | Causey et al. | Nov 2001 | A1 |
20020010423 | Gross et al. | Jan 2002 | A1 |
20020029018 | Jeffrey | Mar 2002 | A1 |
20020040208 | Flaherty et al. | Apr 2002 | A1 |
20020055711 | Lavi et al. | May 2002 | A1 |
20020065488 | Suzuki et al. | May 2002 | A1 |
20020107487 | Preuthun | Aug 2002 | A1 |
20020123740 | Flaherty et al. | Sep 2002 | A1 |
20020161332 | Ramey | Oct 2002 | A1 |
20020169215 | Meng | Nov 2002 | A1 |
20030009133 | Ramey | Jan 2003 | A1 |
20030125671 | Aramata et al. | Jul 2003 | A1 |
20030135159 | Daily et al. | Jul 2003 | A1 |
20030160683 | Blomquist | Aug 2003 | A1 |
20030171717 | Farrugia et al. | Sep 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040092873 | Moberg | May 2004 | A1 |
20040116866 | Gorman et al. | Jun 2004 | A1 |
20040127857 | Shemesh et al. | Jul 2004 | A1 |
20040158172 | Hancock | Aug 2004 | A1 |
20040186419 | Cho | Sep 2004 | A1 |
20040260233 | Garibotto et al. | Dec 2004 | A1 |
20050033234 | Sadowski et al. | Feb 2005 | A1 |
20050065466 | Vedrine | Mar 2005 | A1 |
20050065472 | Cindrich et al. | Mar 2005 | A1 |
20050071487 | Lu et al. | Mar 2005 | A1 |
20050113761 | Faust et al. | May 2005 | A1 |
20050159706 | Wilkinson et al. | Jul 2005 | A1 |
20050171476 | Judson et al. | Aug 2005 | A1 |
20050171512 | Flaherty | Aug 2005 | A1 |
20050177136 | Miller | Aug 2005 | A1 |
20050197650 | Sugimoto et al. | Sep 2005 | A1 |
20050203461 | Flaherty et al. | Sep 2005 | A1 |
20050238507 | Dilanni et al. | Oct 2005 | A1 |
20050283114 | Bresina et al. | Dec 2005 | A1 |
20060013716 | Nason et al. | Jan 2006 | A1 |
20060030816 | Zubry | Feb 2006 | A1 |
20060095014 | Ethelfeld | May 2006 | A1 |
20060122577 | Poulsen et al. | Jun 2006 | A1 |
20060173406 | Hayes et al. | Aug 2006 | A1 |
20060173439 | Thorne et al. | Aug 2006 | A1 |
20060195029 | Shults et al. | Aug 2006 | A1 |
20060211982 | Prestrelski et al. | Sep 2006 | A1 |
20060229569 | Lavi et al. | Oct 2006 | A1 |
20060264889 | Moberg et al. | Nov 2006 | A1 |
20060264890 | Moberg et al. | Nov 2006 | A1 |
20060264894 | Moberg et al. | Nov 2006 | A1 |
20060270987 | Peter | Nov 2006 | A1 |
20060283465 | Nickel et al. | Dec 2006 | A1 |
20060293722 | Slatkine et al. | Dec 2006 | A1 |
20070021733 | Hansen et al. | Jan 2007 | A1 |
20070049865 | Radmer et al. | Mar 2007 | A1 |
20070073228 | Mernoe et al. | Mar 2007 | A1 |
20070118405 | Campbell et al. | May 2007 | A1 |
20070123819 | Mernoe et al. | May 2007 | A1 |
20070167912 | Causey et al. | Jul 2007 | A1 |
20070185449 | Mernoe | Aug 2007 | A1 |
20070197968 | Pongpairochana et al. | Aug 2007 | A1 |
20070203454 | Shermer et al. | Aug 2007 | A1 |
20070233038 | Pruitt et al. | Oct 2007 | A1 |
20070282269 | Carter et al. | Dec 2007 | A1 |
20080021439 | Brittingham et al. | Jan 2008 | A1 |
20080033367 | Haury et al. | Feb 2008 | A1 |
20080033369 | Kohlbrenner et al. | Feb 2008 | A1 |
20080033393 | Edwards et al. | Feb 2008 | A1 |
20080051711 | Mounce et al. | Feb 2008 | A1 |
20080051730 | Bikovsky | Feb 2008 | A1 |
20080059133 | Edwards et al. | Mar 2008 | A1 |
20080097381 | Moberg et al. | Apr 2008 | A1 |
20080108951 | Jerde et al. | May 2008 | A1 |
20080140006 | Eskuri et al. | Jun 2008 | A1 |
20080140018 | Enggaard et al. | Jun 2008 | A1 |
20080147004 | Mann et al. | Jun 2008 | A1 |
20080167641 | Hansen et al. | Jul 2008 | A1 |
20080188813 | Miller et al. | Aug 2008 | A1 |
20080208138 | Lim et al. | Aug 2008 | A1 |
20080215006 | Thorkild | Sep 2008 | A1 |
20080215015 | Cindrich et al. | Sep 2008 | A1 |
20080243087 | Enggaard et al. | Oct 2008 | A1 |
20080249473 | Rutti et al. | Oct 2008 | A1 |
20080262436 | Olson | Oct 2008 | A1 |
20080269687 | Chong et al. | Oct 2008 | A1 |
20080269723 | Mastrototaro et al. | Oct 2008 | A1 |
20080274630 | Shelton et al. | Nov 2008 | A1 |
20080294143 | Tanaka et al. | Nov 2008 | A1 |
20080306449 | Kristensen et al. | Dec 2008 | A1 |
20080312601 | Cane | Dec 2008 | A1 |
20080319416 | Yodfat et al. | Dec 2008 | A1 |
20090041805 | Walker | Feb 2009 | A1 |
20090048347 | Cohen et al. | Feb 2009 | A1 |
20090054750 | Jennewine | Feb 2009 | A1 |
20090069784 | Estes et al. | Mar 2009 | A1 |
20090076453 | Mejlhede et al. | Mar 2009 | A1 |
20090088694 | Carter et al. | Apr 2009 | A1 |
20090088731 | Campbell et al. | Apr 2009 | A1 |
20090093792 | Gross et al. | Apr 2009 | A1 |
20090093793 | Gross et al. | Apr 2009 | A1 |
20090105650 | Wiegel et al. | Apr 2009 | A1 |
20090124977 | Jensen | May 2009 | A1 |
20090143730 | De Polo et al. | Jun 2009 | A1 |
20090143735 | De Polo et al. | Jun 2009 | A1 |
20090149830 | Spector | Jun 2009 | A1 |
20090182277 | Carter | Jul 2009 | A1 |
20090204076 | Liversidge | Aug 2009 | A1 |
20090209896 | Selevan | Aug 2009 | A1 |
20090234319 | Marksteiner | Sep 2009 | A1 |
20090240240 | Hines et al. | Sep 2009 | A1 |
20090253973 | Bashan et al. | Oct 2009 | A1 |
20090259176 | Yairi | Oct 2009 | A1 |
20090281585 | Katzman et al. | Nov 2009 | A1 |
20090299290 | Moberg | Dec 2009 | A1 |
20090299397 | Ruan et al. | Dec 2009 | A1 |
20090326459 | Shipway et al. | Dec 2009 | A1 |
20090326509 | Muse et al. | Dec 2009 | A1 |
20100030156 | Beebe et al. | Feb 2010 | A1 |
20100030198 | Beebe et al. | Feb 2010 | A1 |
20100049128 | McKenzie et al. | Feb 2010 | A1 |
20100049144 | McConnell et al. | Feb 2010 | A1 |
20100057057 | Hayter et al. | Mar 2010 | A1 |
20100076412 | Rush et al. | Mar 2010 | A1 |
20100094255 | Nycz et al. | Apr 2010 | A1 |
20100100076 | Rush et al. | Apr 2010 | A1 |
20100100077 | Rush et al. | Apr 2010 | A1 |
20100106098 | Atterbury et al. | Apr 2010 | A1 |
20100121314 | Iobbi | May 2010 | A1 |
20100137790 | Yodfat | Jun 2010 | A1 |
20100137831 | Tsals | Jun 2010 | A1 |
20100145303 | Yodfat et al. | Jun 2010 | A1 |
20100145305 | Alon | Jun 2010 | A1 |
20100162548 | Leidig | Jul 2010 | A1 |
20100168607 | Miesel | Jul 2010 | A1 |
20100168683 | Cabiri | Jul 2010 | A1 |
20100198157 | Gyrn et al. | Aug 2010 | A1 |
20100204657 | Yodfat et al. | Aug 2010 | A1 |
20100234767 | Sarstedt | Sep 2010 | A1 |
20100234805 | Kaufmann et al. | Sep 2010 | A1 |
20100234830 | Straessler et al. | Sep 2010 | A1 |
20100241065 | Moberg et al. | Sep 2010 | A1 |
20100264931 | Lindegger et al. | Oct 2010 | A1 |
20100274112 | Hoss et al. | Oct 2010 | A1 |
20100274192 | Mernoe | Oct 2010 | A1 |
20100280499 | Yodfat et al. | Nov 2010 | A1 |
20100331826 | Field et al. | Dec 2010 | A1 |
20110034900 | Yodfat et al. | Feb 2011 | A1 |
20110054399 | Chong et al. | Mar 2011 | A1 |
20110054400 | Chong et al. | Mar 2011 | A1 |
20110066131 | Cabiri | Mar 2011 | A1 |
20110125056 | Merchant | May 2011 | A1 |
20110160654 | Hanson et al. | Jun 2011 | A1 |
20110160666 | Hanson et al. | Jun 2011 | A1 |
20110160669 | Gyrn et al. | Jun 2011 | A1 |
20110172645 | Moga et al. | Jul 2011 | A1 |
20110172745 | Na et al. | Jul 2011 | A1 |
20110178472 | Cabiri | Jul 2011 | A1 |
20110201998 | Pongpairochana et al. | Aug 2011 | A1 |
20110238031 | Adair et al. | Sep 2011 | A1 |
20110245773 | Estes et al. | Oct 2011 | A1 |
20110270160 | Mernoe | Nov 2011 | A1 |
20110282282 | Lorenzen et al. | Nov 2011 | A1 |
20110282296 | Harms et al. | Nov 2011 | A1 |
20110295205 | Kaufmann et al. | Dec 2011 | A1 |
20110313238 | Reichenbach et al. | Dec 2011 | A1 |
20110319861 | Wilk | Dec 2011 | A1 |
20110319919 | Curry et al. | Dec 2011 | A1 |
20120004602 | Hanson et al. | Jan 2012 | A1 |
20120010594 | Holt et al. | Jan 2012 | A1 |
20120022344 | Kube | Jan 2012 | A1 |
20120022499 | Anderson et al. | Jan 2012 | A1 |
20120029431 | Hwang et al. | Feb 2012 | A1 |
20120035546 | Cabiri | Feb 2012 | A1 |
20120041364 | Smith | Feb 2012 | A1 |
20120041414 | Estes et al. | Feb 2012 | A1 |
20120071828 | Tojo et al. | Mar 2012 | A1 |
20120096953 | Bente, IV et al. | Apr 2012 | A1 |
20120096954 | Vazquez et al. | Apr 2012 | A1 |
20120101436 | Bazargan et al. | Apr 2012 | A1 |
20120108933 | Liang et al. | May 2012 | A1 |
20120129362 | Hampo et al. | May 2012 | A1 |
20120160033 | Kow et al. | Jun 2012 | A1 |
20120165733 | Bazargan et al. | Jun 2012 | A1 |
20120165780 | Bazargan et al. | Jun 2012 | A1 |
20120226234 | Bazargan et al. | Sep 2012 | A1 |
20120259282 | Alderete, Jr. et al. | Oct 2012 | A1 |
20130012875 | Gross et al. | Jan 2013 | A1 |
20130068319 | Plumptre et al. | Mar 2013 | A1 |
20130085457 | Schiff et al. | Apr 2013 | A1 |
20130089992 | Yang | Apr 2013 | A1 |
20130096509 | Avery et al. | Apr 2013 | A1 |
20130110049 | Cronenberg et al. | May 2013 | A1 |
20130133438 | Kow et al. | May 2013 | A1 |
20130237953 | Kow et al. | Sep 2013 | A1 |
20130245595 | Kow et al. | Sep 2013 | A1 |
20130245596 | Cabiri et al. | Sep 2013 | A1 |
20130253419 | Favreau | Sep 2013 | A1 |
20130253420 | Favreau | Sep 2013 | A1 |
20130253421 | Favreau | Sep 2013 | A1 |
20130296799 | Degtiar et al. | Nov 2013 | A1 |
20130304021 | Cabiri et al. | Nov 2013 | A1 |
20130323699 | Edwards et al. | Dec 2013 | A1 |
20130331791 | Gross et al. | Dec 2013 | A1 |
20140055073 | Favreau | Feb 2014 | A1 |
20140055076 | Favreau | Feb 2014 | A1 |
20140058349 | Bazargan et al. | Feb 2014 | A1 |
20140083517 | Moia et al. | Mar 2014 | A1 |
20140094755 | Bazargan et al. | Apr 2014 | A1 |
20140128807 | Moberg et al. | May 2014 | A1 |
20140128835 | Moberg et al. | May 2014 | A1 |
20140135692 | Alderete, Jr. et al. | May 2014 | A1 |
20140135694 | Moberg et al. | May 2014 | A1 |
20140142499 | Moberg et al. | May 2014 | A1 |
20140148784 | Anderson et al. | May 2014 | A1 |
20140148785 | Moberg et al. | May 2014 | A1 |
20140163522 | Alderete, Jr. et al. | Jun 2014 | A1 |
20140194819 | Maule et al. | Jul 2014 | A1 |
20140194854 | Tsals | Jul 2014 | A1 |
20140207064 | Yavorsky | Jul 2014 | A1 |
20140207065 | Yavorsky | Jul 2014 | A1 |
20140207066 | Yavorsky | Jul 2014 | A1 |
20140213975 | Clemente et al. | Jul 2014 | A1 |
20140236087 | Alderete, Jr. et al. | Aug 2014 | A1 |
20140261758 | Wlodarczyk et al. | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
1224341 | Jul 1999 | CN |
1747683 | Mar 2006 | CN |
1863566 | Nov 2006 | CN |
1929884 | Mar 2007 | CN |
101090749 | Dec 2007 | CN |
101460207 | Jun 2009 | CN |
101970033 | Feb 2011 | CN |
201941304 | Aug 2011 | CN |
102186733 | Sep 2011 | CN |
102256657 | Nov 2011 | CN |
1064693 | Sep 1959 | DE |
0017412 | Oct 1980 | EP |
0222656 | May 1987 | EP |
0401179 | Dec 1990 | EP |
1530979 | May 2005 | EP |
1666080 | Jun 2006 | EP |
2060606 | May 2009 | EP |
2498589 | Sep 2012 | EP |
H07-194701 | Aug 1995 | JP |
H09-505758 | Jun 1997 | JP |
2001-512992 | Aug 2001 | JP |
2002-505601 | Feb 2002 | JP |
2002-507459 | Mar 2002 | JP |
2002-528676 | Sep 2002 | JP |
2003-501157 | Jan 2003 | JP |
2003-527138 | Sep 2003 | JP |
2003-534061 | Nov 2003 | JP |
2004-501721 | Jan 2004 | JP |
2004-512100 | Apr 2004 | JP |
2005-523127 | Aug 2005 | JP |
2005-270629 | Oct 2005 | JP |
2007-509661 | Apr 2007 | JP |
2008-534131 | Aug 2008 | JP |
2008-220961 | Sep 2008 | JP |
2009-502273 | Jan 2009 | JP |
9009202 | Aug 1990 | WO |
9307922 | Apr 1993 | WO |
9407553 | Apr 1994 | WO |
9513838 | May 1995 | WO |
9609083 | Mar 1996 | WO |
9632975 | Oct 1996 | WO |
9700091 | Jan 1997 | WO |
9710012 | Mar 1997 | WO |
9733638 | Sep 1997 | WO |
9857683 | Dec 1998 | WO |
9929151 | Jun 1999 | WO |
9959665 | Nov 1999 | WO |
0025844 | May 2000 | WO |
0187384 | Nov 2001 | WO |
0189607 | Nov 2001 | WO |
0189613 | Nov 2001 | WO |
0202165 | Jan 2002 | WO |
0234315 | May 2002 | WO |
0272182 | Sep 2002 | WO |
03090833 | Nov 2003 | WO |
2004032990 | Apr 2004 | WO |
2004105841 | Dec 2004 | WO |
2005018703 | Mar 2005 | WO |
2005037350 | Apr 2005 | WO |
2006037434 | Apr 2006 | WO |
06069380 | Jun 2006 | WO |
2006102676 | Sep 2006 | WO |
2006104806 | Oct 2006 | WO |
2007051563 | May 2007 | WO |
2007056504 | May 2007 | WO |
2008001377 | Jan 2008 | WO |
2008014908 | Feb 2008 | WO |
2008057976 | May 2008 | WO |
2008072229 | Jun 2008 | WO |
2008076459 | Jun 2008 | WO |
2008078318 | Jul 2008 | WO |
2009044401 | Apr 2009 | WO |
2009046989 | Apr 2009 | WO |
2009125398 | Oct 2009 | WO |
2009144085 | Dec 2009 | WO |
2010078227 | Jul 2010 | WO |
2010078242 | Jul 2010 | WO |
2011075105 | Jun 2011 | WO |
2011090955 | Jul 2011 | WO |
2011090956 | Jul 2011 | WO |
2011156373 | Dec 2011 | WO |
2012032411 | Mar 2012 | WO |
2012040528 | Mar 2012 | WO |
2012160157 | Nov 2012 | WO |
2013173092 | Nov 2013 | WO |
2014070453 | May 2014 | WO |
2014179774 | Nov 2014 | WO |
Entry |
---|
Extended European Search Report dated Aug. 7, 2014 in EP Application No. 1417477.4. |
Office Action dated Aug. 6, 2014 in EP Application No. 11 707 942.6. |
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550069. |
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550068. |
Office Action dated Aug. 26, 2014 in CN Application No. 201180006567.4. |
Int'l Preliminary Report on Patentability dated Oct. 9, 2014 in Int'l Application No. PCT/US2013/033118. |
Office Action dated Oct. 9, 2014 in U.S. Appl. No. 13/873,335. |
Int'l Search Report dated May 13, 2009 in Int'l Application No. PCT/IL2008/001312. |
Int'l Preliminary Report on Patentability dated Apr. 7, 2010 in Int'l Application No. PCT/IL2008/001312; Written Opinion. |
Int'l Search Report dated Apr. 26, 2010 in Int'l Application No. PCT/US2009/069552. |
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,666. |
Office Action dated Sep. 21, 2010 in U.S. Appl. No. 12/244,666. |
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,688. |
Office Action dated Sep. 2, 2010 in U.S. Appl. No. 12/244,688. |
Office Action dated Sep. 30, 2010 in U.S. Appl. No. 12/689,250. |
Int'l Search Report dated Jan. 12, 2011 in Int'l Application No. PCT/US2010/048556; Written Opinion. |
International Preliminary Report on Patentability dated Jul. 5, 2011 in International Application No. PCT/US2009/069552; Written Opinion. |
Office Action dated Jul. 13, 2011 in U.S. Appl. No. 12/559,563. |
Int'l Preliminary Report on Patentability dated Sep. 1, 2011 in Int'l Application No. PCT/US2010/048556. |
Office Action dated Sep. 6, 2011 in U.S. Appl. No. 12/345,818. |
Office Action dated Feb. 21, 2012 in U.S. Appl. No. 12/689,249. |
Int'l Search Report dated Jun. 17, 2011 in Int'l Application No. PCT/US2011/021604. |
Int'l Search Report dated Oct. 12, 2011 in Int'l Application No. PCT/US2011/021605. |
Office Action dated Oct. 28, 2011 in U.S. Appl. No. 12/615,828. |
Int'l Search Report dated Sep. 22, 2011 in Int'l Application No. PCT/IL11/00368; Written Opinion. |
U.S. Appl. No. 13/521,181 by Cabiri, filed Jul. 9, 2012. |
U.S. Appl. No. 13/521,167 by Cabiri, filed Jul. 9, 2012. |
Office Action dated May 16, 2012 in U.S. Appl. No. 12/615,828. |
Office Action dated Jul. 2, 2012 in U.S. Appl. No. 13/272,555. |
Office Action dated May 3, 2012 in CN Application No. 200880117084.X. |
U.S. Appl. No. 13/472,112 by Cabiri, filed May 15, 2012. |
U.S. Appl. No. 13/429,840 by Cabiri, filed Mar. 26, 2012. |
Int'l Preliminary Report on Patentability dated Aug. 2, 2012 in Int'l Application No. PCT/US2011/021604. |
U.S. Appl. No. 13/643,470 by Alon, filed Oct. 25, 2012. |
U.S. Appl. No. 13/733,516 by Cabiri, filed Jan. 3, 2013. |
U.S. Appl. No. 14/593,051 by Gross, filed Jan. 9, 2015. |
Office Action dated Jan. 8, 2013 in JP Application No. 2010-527595. |
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US2011/021604. |
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US2011/021605. |
English translation of an Office Action dated Jan. 30, 2013 in CN Application No. 200880117084.X. |
U.S. Appl. No. 14/193,692 by Gross, filed Feb. 28, 2014. |
Office Action dated Feb. 4, 2014 in EP Application No. 11 707 942.6. |
English translation of an Office Action dated Mar. 5, 2014 in CN Application No. 200880117084.X. |
Int'l Search Report and Written Opinion dated Apr. 3, 2014 in Int'l Application No. PCT/US2013/078040. |
Extended European Search Report dated Mar. 27, 2014 in EP Application No. 14154717.4. |
Office Action dated Feb. 28, 2014 in CN Application No. 201180006571.0. |
U.S. Appl. No. 14/683,193 by Cabiri, filed Apr. 10, 2015. |
Office Action dated Feb. 20, 2015 in U.S. Appl. No. 13/521,181 by Cabiri. |
Office Action dated Feb. 24, 2015 in U.S. Appl. No. 14/258,661 by Cabiri. |
U.S. Appl. No. 14/638,525 by Filman, filed Mar. 4, 2015. |
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166596.8. |
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 13/643,470 by Alon. |
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 12/244,666 by Gross. |
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166591.9. |
Office Action dated Mar. 10, 2015 in CN Application No. 201180006567.4. |
Office Action dated Mar. 31, 2015 in JP Application No. 2012-550068. |
U.S. Appl. No. 13/873,335 by Filman, filed Apr. 30, 2013. |
U.S. Appl. No. 13/892,905 by Cabiri, filed May 13, 2013. |
U.S. Appl. No. 13/874,121 by Degtiar, filed Apr. 30, 2013. |
U.S. Appl. No. 13/874,085 by Cabiri, filed Apr. 30, 2013. |
U.S. Appl. No. 13/874,017 by Cabiri, filed Apr. 30, 2013. |
U.S. Appl. No. 14/258,661 by Cabiri, filed Apr. 22, 2014. |
Int'l Search Report and Written Opinion dated Jan. 7, 2014 in Int'l Application No. PCT/US2013/065211. |
Office Action dated May 23, 2014 in U.S. Appl. No. 13/472,112 by Cabiri. |
Office Action dated Jun. 3, 2014 in JP Application No. 2010-527595. |
Office Action dated Jul. 7, 2014 in U.S. Appl. No. 12/244,666 by Gross. |
Int'l Search Report and Written Opinion dated Jul. 31, 2014 in Int'l Application No. PCT/US2014/033598. |
Int'l Search Report and Written Opinion dated Jul. 26, 2013 in Int'l Application No. PCT/US2012/039465. |
Int'l Search Report and Written Opinion dated Aug. 5, 2013 in Int'l Application No. PCT/US2013/033118. |
U.S. Appl. No. 13/964,651 by Gross, filed Aug. 12, 2013. |
Office Action dated Aug. 15, 2013 in CN Application No. 200880117084.X. |
Office Action dated Nov. 5, 2014 in U.S. Appl. No. 13/643,470 by Alon. |
U.S. Appl. No. 14/553,399 by Cabiri, filed Nov. 25, 2014. |
Office Action dated Nov. 2, 2014 in CN Application No. 201180006571.0. |
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/472,112 by Cabiri. |
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/429,840 by Cabiri. |
Int'l Preliminary Report on Patentability dated Nov. 27, 2014 in Int'l Application No. PCT/US2013/039465. |
Office Action dated Oct. 9, 2013 in IL Application No. 208634. |
Office Action dated Nov. 5, 2013 in JP Application No. 2010-527595. |
Office Action dated Sep. 29, 2013 in CN Application No. 201080040968.7. |
Office Action dated Nov. 4, 2013 in EP Application No. 11 709 234.6. |
Office Action dated Dec. 17, 2013 in JP Application No. 2012-529808. |
Office Action dated Dec. 10, 2013 in CN Application No. 201180006567.4. |
Office Action dated Jan. 8, 2014 in U.S. Appl. No. 13/521,167 by Cabiri. |
U.S. Appl. No. 29/479,307 by Norton, filed Jan. 14, 2014. |
Office Action dated Jul. 31, 2015 in U.S. Appl. No. 13/521,181 by Cabiri. |
Office Action dated Aug. 13, 2015 in U.S. Appl. No. 14/553,399 by Cabiri. |
Notice of Allowance dated Aug. 24, 2015 in U.S. Appl. No. 29/479,307 by Norton. |
Daikyo Crystal Zenith® polymer, Manufactured by Daikyo Seiko, Ltd. (Jun. 25, 2008). |
Copaxone®, Manufactured by Teva Pharmaceutical Industries Ltd. (2009). |
Int'l Preliminary Report on Patentability dated May 14, 2015 in Int'l Application No. PCT/US2013/065211. |
Office Action dated May 7, 2015 in JP Application No. 2012-550069. |
Office Action dated May 13, 2015 in CN Application No. 201380025566.3. |
U.S. Appl. No. 14/715,791 by Cabiri, filed May 19, 2015. |
U.S. Appl. No. 14/725,009 by Bar-El, filed May 29, 2015. |
Office Action dated May 1, 2015 in U.S. Appl. No. 14/638,525 by Filman. |
Office Action dated Jan. 15, 2016 in U.S. Appl. No. 13/472,112 by Cabiri. |
Office Action dated Sep. 9, 2015 in U.S. Appl. No. 13/643,470 by Alon. |
U.S. Appl. No. 14/850,450 by Gross, filed Sep. 10, 2015. |
U.S. Appl. No. 14/861,478 by Cabiri, filed Sep. 22, 2015. |
U.S. Appl. No. 14/880,673 by Cabiri, filed Oct. 12, 2015. |
Office Action dated Sep. 18, 2015 in U.S. Appl. No. 13/874,085 by Cabiri. |
Office Action dated May 24, 2017 in CN Application No. 2013800571961. |
Office Action dated Nov. 2, 2016 in CN Application No. 2013800571961. |
Search Report dated Nov. 2, 2016 in CN Application No. 2013800571961. |
Office Action dated Sep. 13, 2017 in EP Application No. 13783458.6. |
Number | Date | Country | |
---|---|---|---|
20140128815 A1 | May 2014 | US |